XtalPi And DoveTree Finalize $6B AI Drug Discovery Agreement
XtalPi has signed a definitive agreement with DoveTree Medicines for an AI- and robotics-powered drug discovery collaboration valued at up …
All Posts
Chai Discovery Raises $70M to Expand Zero-Shot Biologics Design AI Platform
Chai Discovery, an AI drug discovery company founded in late 2024 and backed by OpenAI, has raised $70 million in …
WVU Cancer Institute Adopts Ryght AI Tools for Trial Matching and Enrollment
West Virginia University (WVU) Cancer Institute has joined Ryght AI’s clinical trial site network, giving the academic cancer center access …
NIH Foundation Launches Industry-Backed Program to Advance Non-Animal Testing Methods Toward Regulatory Use
The Foundation for the National Institutes of Health (FNIH) has launched the Validation and Qualification Network (VQN), a multi-stakeholder initiative …
Recursion Reports Q2 2025 with $7M Sanofi Milestone, Announces Clinical Updates
Recursion Pharmaceuticals, a clinical-stage TechBio company headquartered in Salt Lake City, a founding member of BioHive, Utah’s life sciences collective, …
Lantern Pharma Launches AI Platform for Blood-Brain Barrier Permeability Prediction, Completes Japan Trial Enrollment
Lantern Pharma has announced two major milestones: completion of patient enrollment in Japan for its Phase 2 HARMONIC trial of …
Ultromics Gets $55M to Spot Hidden Heart Failure with AI Ultrasound
Oxford-based Ultromics has secured $55 million in Series C funding to expand deployment of its AI-powered echocardiography software across the …
Synchron Becomes First to Achieve Native Thought-Control of Apple iPad Using Brain-Computer Interface
The New York-based medtech Synchron, a brain-computer interface (BCI) company backed by DARPA, Gates Frontier, and Bezos Expeditions, has become …
Neuralink Begins UK Clinical Trial of Brain Implant for People with Paralysis
Neuralink, Elon Musk’s brain computer interface (BCI) developing company, has launched its first clinical trial in the UK to evaluate …
OpenAI-Backed Ambience Raises $243M in Series C, Reaching $1B+ Valuation
San Francisco-based AI startup Ambience Healthcare has raised $243 million in Series C funding, bringing its valuation to over $1 …
Profluent Publishes AI-Designed Genome Editor in Nature, Releases Largest CRISPR Dataset
Profluent, an AI-first protein design company founded in 2022 in Berkeley, CA, has published research in Nature on OpenCRISPR-1, an …
AI-Native Formation Bio Licenses Monoclonal Antibody After $372M Raise in 2024
Formation Bio has licensed global rights to a first-in-class anti-CD226 monoclonal antibody from IMIDomics, aiming to expand its immunology pipeline …